Literature DB >> 7527767

Somatosensory evoked potentials at rest and during movement in Parkinson's disease: evidence for a specific apomorphine effect on the frontal N30 wave.

G Cheron1, T Piette, A Thiriaux, J Jacquy, E Godaux.   

Abstract

Studies attempting to relate the abnormalities of the frontal N30 components of the somatosensory evoked potentials (SEPs) to motor symptoms in Parkinson's disease (PD) have shown contradictory results. We recorded the frontal and parietal SEPs to median nerve stimulation in 2 groups of PD patients: a group of 17 patients presenting the wearing-off phenomenon, and a group of 10 untreated PD patients. The results were compared with a group of 13 healthy volunteers of the same age and with a group of 10 non-parkinsonian patients. All parkinsonian and non-parkinsonian patients were studied before ("off" condition) and after a subcutaneous injection of apomorphine ("on" condition). The gating effects of a voluntary movement (clenching of the hand) on the SEPs were also studied for the wearing-off group of PD patients (in states off and on) in comparison with the healthy subjects. At rest and in the off condition the amplitude of the frontal N30 was significantly reduced in the 2 groups of PD patients. We demonstrate that the movement gating ability of the PD patient is preserved in spite of the reduced amplitude of the frontal N30. This result suggests that the specific change in the frontal N30 in PD is not the consequence of a continuous gating of the sensory inflow by a motor corollary discharge. Clinical motor improvement induced by apomorphine was associated with a significant enhancement of the frontal N30 wave. In contrast, the subcortical P14 and N18 waves and the cortical N20, P22, P27 and N45 were not statistically modified by the drug. Apomorphine infusion did not change the absolute reduced voltage of the N30 reached during the movement gating. While the frontal N30 component of the non-parkinsonian patients was significantly lower in comparison to healthy subjects, this wave did not change after the apomorphine administration. In the wearing-off PD patient group the frontal N30 increment was positively correlated with the number of off hours per day. This specific apomorphine sensitivity of the frontal N30 was interpreted as a physiological index of the dopaminergic modulatory control exerted on the neuronal structures implicated in the generation of the frontal N30.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7527767     DOI: 10.1016/0168-5597(94)90133-3

Source DB:  PubMed          Journal:  Electroencephalogr Clin Neurophysiol        ISSN: 0013-4694


  11 in total

1.  Movement gating of beta/gamma oscillations involved in the N30 somatosensory evoked potential.

Authors:  Ana Maria Cebolla; Caty De Saedeleer; Ana Bengoetxea; Françoise Leurs; Costantino Balestra; Pablo d'Alcantara; Ernesto Palmero-Soler; Bernard Dan; Guy Cheron
Journal:  Hum Brain Mapp       Date:  2009-05       Impact factor: 5.038

2.  Modulatory effects of movement sequence preparation and covert spatial attention on early somatosensory input to non-primary motor areas.

Authors:  Matt J N Brown; W Richard Staines
Journal:  Exp Brain Res       Date:  2014-10-31       Impact factor: 1.972

3.  Non-dominant hand movement facilitates the frontal N30 somatosensory evoked potential.

Authors:  Wynn Legon; Jennifer K Dionne; Sean K Meehan; W Richard Staines
Journal:  BMC Neurosci       Date:  2010-09-07       Impact factor: 3.288

4.  Hand somatosensory subcortical and cortical sources assessed by functional source separation: an EEG study.

Authors:  Camillo Porcaro; Gianluca Coppola; Giorgio Di Lorenzo; Filippo Zappasodi; Alberto Siracusano; Francesco Pierelli; Paolo Maria Rossini; Franca Tecchio; Stefano Seri
Journal:  Hum Brain Mapp       Date:  2009-02       Impact factor: 5.038

5.  Short-Term Effects of Thoracic Spine Manipulation on the Biomechanical Organisation of Gait Initiation: A Randomized Pilot Study.

Authors:  Sébastien Ditcharles; Eric Yiou; Arnaud Delafontaine; Alain Hamaoui
Journal:  Front Hum Neurosci       Date:  2017-06-30       Impact factor: 3.169

6.  Clinical factors affecting evoked magnetic fields in patients with Parkinson's disease.

Authors:  Ryoji Naganuma; Ichiro Yabe; Megumi Takeuchi; Kirari Morishita; Shingo Nakane; Ryoken Takase; Ikuko Takahashi-Iwata; Masaaki Matsushima; Mika Otsuki; Hideaki Shiraishi; Hidenao Sasaki
Journal:  PLoS One       Date:  2020-09-17       Impact factor: 3.240

7.  Pure phase-locking of beta/gamma oscillation contributes to the N30 frontal component of somatosensory evoked potentials.

Authors:  Guy Cheron; Ana Maria Cebolla; Caty De Saedeleer; Ana Bengoetxea; Françoise Leurs; Axelle Leroy; Bernard Dan
Journal:  BMC Neurosci       Date:  2007-09-18       Impact factor: 3.288

8.  Manipulation of Dysfunctional Spinal Joints Affects Sensorimotor Integration in the Prefrontal Cortex: A Brain Source Localization Study.

Authors:  Dina Lelic; Imran Khan Niazi; Kelly Holt; Mads Jochumsen; Kim Dremstrup; Paul Yielder; Bernadette Murphy; Asbjørn Mohr Drewes; Heidi Haavik
Journal:  Neural Plast       Date:  2016-03-07       Impact factor: 3.599

9.  N30 Somatosensory Evoked Potential Is Negatively Correlated with Motor Function in Parkinson's Disease.

Authors:  Suk Yun Kang; Hyeo-Il Ma
Journal:  J Mov Disord       Date:  2016-01-25

10.  Dopaminergic Modulation of Sensory Attenuation in Parkinson's Disease: Is There an Underlying Modulation of Beta Power?

Authors:  Antonella Macerollo; Patricia Limousin; Prasad Korlipara; Tom Foltynie; Mark J Edwards; James Kilner
Journal:  Front Neurol       Date:  2019-09-18       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.